Clinical trials for rare diseases are reaching a critical inflection point as traditional designs struggle to meet the demands for speed, efficiency, and patient access. External Control Arms (ECAs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback